Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference
News > Health News
Audio By Carbonatix
7:30 AM on Tuesday, January 6
The Associated Press
CHICAGO--(BUSINESS WIRE)--Jan 6, 2026--
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, will participate in the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, California.
Tempus Founder and CEO Eric Lefkofsky will deliver a presentation, followed by a live Q&A session, on January 12th, 2026 from 1:30 - 2:10PM PST. The presentation will be available via live webcast here:
About Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20260106129559/en/
CONTACT: Hanah Heintzelman
hanah.heintzelman@tempus.com
KEYWORD: CALIFORNIA ILLINOIS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: SOFTWARE BIOTECHNOLOGY PHARMACEUTICAL HEALTH ARTIFICIAL INTELLIGENCE DATA MANAGEMENT HEALTH TECHNOLOGY TECHNOLOGY
SOURCE: Tempus AI, Inc.
Copyright Business Wire 2026.
PUB: 01/06/2026 08:30 AM/DISC: 01/06/2026 08:30 AM
http://www.businesswire.com/news/home/20260106129559/en
